$2.49T
Total marketcap
$76.73B
Total volume
BTC 52.05%     ETH 14.23%
Dominance

Cybin Inc. R7E1.F Stock

0.33 EUR {{ price }} -0.092115% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
247.2M EUR
LOW - HIGH [24H]
0.3 - 0.33 EUR
VOLUME [24H]
73.4K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.2 EUR

Cybin Inc. Price Chart

Cybin Inc. R7E1.F Financial and Trading Overview

Cybin Inc. stock price 0.33 EUR
Previous Close 0.22 EUR
Open 0.23 EUR
Bid 0.21 EUR x N/A
Ask 0.24 EUR x N/A
Day's Range 0.23 - 0.23 EUR
52 Week Range 0.21 - 1.12 EUR
Volume 10K EUR
Avg. Volume 237 EUR
Market Cap 44.49M EUR
Beta (5Y Monthly) 1.88952
PE Ratio (TTM) N/A
EPS (TTM) -0.2 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 8.08 EUR

R7E1.F Valuation Measures

Enterprise Value 20.29M EUR
Trailing P/E N/A
Forward P/E -0.8923077
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.7864407
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.376

Trading Information

Cybin Inc. Stock Price History

Beta (5Y Monthly) 1.88952
52-Week Change -60.84%
S&P500 52-Week Change 20.43%
52 Week High 1.12 EUR
52 Week Low 0.21 EUR
50-Day Moving Average 0.29 EUR
200-Day Moving Average 0.42 EUR

R7E1.F Share Statistics

Avg. Volume (3 month) 237 EUR
Avg. Daily Volume (10-Days) 1K EUR
Shares Outstanding 191.76M
Float 156.66M
Short Ratio N/A
% Held by Insiders 22.28%
% Held by Institutions 7.86%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End March 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -43.43%
Return on Equity (ttm) -71.33%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -53938000 EUR
Net Income Avi to Common (ttm) -51867000 EUR
Diluted EPS (ttm) -0.21
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 22.64M EUR
Total Cash Per Share (mrq) 0.12 EUR
Total Debt (mrq) 0 EUR
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 6.891
Book Value Per Share (mrq) 0.295

Cash Flow Statement

Operating Cash Flow (ttm) -46314000 EUR
Levered Free Cash Flow (ttm) -32884624 EUR

Profile of Cybin Inc.

Country Germany
State ON
City Toronto
Address 100 King Street West
ZIP M5X 1C9
Phone N/A
Website https://www.cybin.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 50

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Q&A For Cybin Inc. Stock

What is a current R7E1.F stock price?

Cybin Inc. R7E1.F stock price today per share is 0.33 EUR.

How to purchase Cybin Inc. stock?

You can buy R7E1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cybin Inc.?

The stock symbol or ticker of Cybin Inc. is R7E1.F.

Which industry does the Cybin Inc. company belong to?

The Cybin Inc. industry is Biotechnology.

How many shares does Cybin Inc. have in circulation?

The max supply of Cybin Inc. shares is 759.69M.

What is Cybin Inc. Price to Earnings Ratio (PE Ratio)?

Cybin Inc. PE Ratio is now.

What was Cybin Inc. earnings per share over the trailing 12 months (TTM)?

Cybin Inc. EPS is -0.2 EUR over the trailing 12 months.

Which sector does the Cybin Inc. company belong to?

The Cybin Inc. sector is Healthcare.